Baker, S. J., Cosenza, S. C., Ramana Reddy, M., & Premkumar Reddy, E. (2019). Rigosertib ameliorates the effects of oncogenic KRAS signaling in a murine model of myeloproliferative neoplasia. Oncotarget.
Chicago-stil citatBaker, Stacey J., Stephen C. Cosenza, M.V Ramana Reddy, och E. Premkumar Reddy. "Rigosertib Ameliorates the Effects of Oncogenic KRAS Signaling in a Murine Model of Myeloproliferative Neoplasia." Oncotarget 2019.
MLA-referensBaker, Stacey J., Stephen C. Cosenza, M.V Ramana Reddy, och E. Premkumar Reddy. "Rigosertib Ameliorates the Effects of Oncogenic KRAS Signaling in a Murine Model of Myeloproliferative Neoplasia." Oncotarget 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.